Immune Thrombocytopenic Purpura (ITP) Clinical Trials

• AMG 531 Versus Medical Standard of Care for Immune (Idiopathic) Thrombocytopenic Purpura
  ClinicalTrials.gov Identifier: NCT00415532 - Active, not recruiting
  Idiopathic Thrombocytopenic Purpura; Thrombocytopenia; Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP); Thrombocytopenic Purpura
  
• Retrospective & Prospective Observational Study of Subjects With ITP
  ClinicalTrials.gov Identifier: NCT00454857 - Active, not recruiting
  Idiopathic Thrombocytopenic Purpura; Thrombocytopenia; Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP); Thrombocytopenic Purpura
  
• Safety and Efficacy Study of AMG 531 to Treat ITP in Pediatric Subjects
  ClinicalTrials.gov Identifier: NCT00515203 - Recruiting
  Idiopathic Thrombocytopenic Purpura; Thrombocytopenia in Pediatric Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP); Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
  
• Pilot Study of Rituximab for the Treatment of Acute Immune Thrombocytopenic Purpura (ITP)
  ClinicalTrials.gov Identifier: NCT00372892 - Recruiting
  Purpura, Thrombocytopenic, Idiopathic
  
• A Trial to Treat Patients with ITP Who Do Not Achieve a Durable Response to Rituxan Alone
  ClinicalTrials.gov Identifier: NCT00161564 - Recruiting
  Idiopathic Thrombocytopenic Purpura (ITP)
  
• A Phase I Study of Recombinant Human CD4 Immunoglobulin G (rCD4-lgG) in Patients with HIV-Associated Immune Thrombocytopenic Purpura
  ClinicalTrials.gov Identifier: NCT00002250 - Completed
  Immune thrombocytopenic purpura ( ITP ); HIV Infections
  
• Study of Veltuzumab (hA20) at Different Doses in Patients With ITP
  ClinicalTrials.gov Identifier: NCT00547066 - Active, not recruiting
  Purpura, Thrombocytopenic, Idiopathic; Autoimmune Thrombocytopenic Purpura; Purpura, Thrombocytopenic, Autoimmune
  
• Treatment of Chronic Immune Thrombocytopenic Purpura (ITP) With Intravenous Immunoglobulin IgPro10
  ClinicalTrials.gov Identifier: NCT00168038 - Completed
  Immune Thrombocytopenic Purpura
  
• An Epidemiological Study of Subjects with Immune Thrombocytopenic Purpura to Evaluate the Relationship Between Platelet Counts, Endogenous Thrombopoietin Levels, Endogenous Anti-Thrombopoietin Antibodies, and Selected Autoimmune Markers
  ClinicalTrials.gov Identifier: NCT00005570 - Completed
  Purpura, Thrombocytopenic, Idiopathic; immune thrombocytopenic purpura
  
• Evaluating the Safety and Efficacy of AMG 531 in Thrombocytopenic Subjects with Immune Thrombocytopenic Purpura (ITP)
  ClinicalTrials.gov Identifier: NCT00111475 - Completed
  Idiopathic Thrombocytopenic Purpura
  
• Amgen Megakaryopoiesis Protein 2 (AMG 531) in Thrombocytopenic Subjects with Immune Thrombocytopenic Purpura (ITP)
  ClinicalTrials.gov Identifier: NCT00117143 - Completed
  Purpura, Thrombocytopenic
  
• An Open Label Study of AMG 531 for Subjects With ITP
  ClinicalTrials.gov Identifier: NCT00508820 - Recruiting
  Idiopathic Thrombocytopenic Purpura; Thrombocytopenia; Thrombocytopenic Purpura
  
• Cohort of Children With Acute Immune or Idiopathic Thrombocytopenic Purpura (ITP) : a Prospective Study in Pays De La Loire
  ClinicalTrials.gov Identifier: NCT00331357 - Not yet recruiting
  Acute Idiopathic Thrombocytopenic Purpura
  
• A Phase 1, Open-Label, Multiple-Dose, Dose Escalation Study of the Safety and Tolerability of Staphylococcal Protein A in Adult Patients With Chronic Idiopathic Thrombocytopenic Purpura (ITP)
  ClinicalTrials.gov Identifier: NCT00571467 - Not yet recruiting
  Idiopathic Thrombocytopenic Purpura (ITP)
  
• Open Label Extension Study of AMG 531 in Japanese Subjects With ITP
  ClinicalTrials.gov Identifier: NCT00440037 - Recruiting
  Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
  
• Randomized Placebo-Controlled Idiopathic Thrombocytopenic Purpura (ITP) Study With Eltrombopag
  ClinicalTrials.gov Identifier: NCT00370331 - Active, not recruiting
  Idiopathic Thrombocytopenic Purpura
  
• SB497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo in Adults with Refractory Immune Thrombocytopenic Purpura
  ClinicalTrials.gov Identifier: NCT00102739 - Active, not recruiting
  Purpura, Thrombocytopenic, Idiopathic
  
• AMG 531 Treatment of Thrombocytopenic Subjects with Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Prior to Splenectomy
  ClinicalTrials.gov Identifier: NCT00102336 - Active, not recruiting
  Thrombocytopenia
  
• AMG 531 Treatment of Thrombocytopenic Subjects with Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Refractory to Splenectomy
  ClinicalTrials.gov Identifier: NCT00102323 - Active, not recruiting
  Thrombocytopenia
  
• Ig NextGen 10% in ITP Patients
  ClinicalTrials.gov Identifier: NCT00362349 - Recruiting
  Idiopathic Thrombocytopenic Purpura (ITP)
  
• Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders
  ClinicalTrials.gov Identifier: NCT00157079 - Completed
  Primary Immunodeficiency Disorders; Immune Thrombocytopenic Purpura (ITP); Kawasaki syndrome
  
• A Study to Find How Safe and Effective GAMMAPLEX® is in Subjects With Chronic Idiopathic Thrombocytopenic Purpura (ITP)
  ClinicalTrials.gov Identifier: NCT00504075 - Recruiting
  Chronic Idiopathic Thrombocytopenic Purpura
  
• Open Label Extension Study of AMG 531 in Thrombocytopenic Subjects with Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
  ClinicalTrials.gov Identifier: NCT00116688 - Recruiting
  Thrombocytopenia
  
• Treatment of ITP with Subcutaneously Administered Anti-D
  ClinicalTrials.gov Identifier: NCT00128882 - Recruiting
  Idiopathic Thrombocytopenic Purpura
  
• Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With ITP
  ClinicalTrials.gov Identifier: NCT00441090 - Recruiting
  Chronic Idiopathic Thrombocytopenic Purpura (ITP)
  
• Safety Study of AMG 531 in Japanese Subjects With ITP
  ClinicalTrials.gov Identifier: NCT00305435 - Completed
  Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
  
• A Randomized Study of IVIG Vs. IVIG With High Dose Methylprednisolone in Childhood ITP.
  ClinicalTrials.gov Identifier: NCT00376077 - Recruiting
  Immune Thrombocytopenic Purpura
  
• Clinical Evaluation of SB-497115-GR in Chronic Idiopathic Thrombocytopenic Purpura (ITP)
  ClinicalTrials.gov Identifier: NCT00540423 - Not yet recruiting
  Chronic Idiopathic Thrombocytopenic Purpura
  
• Phase II Study of Rituximab in Patients With Immune Thrombocytopenic Purpura
  ClinicalTrials.gov Identifier: NCT00005652 - Active, not recruiting
  Purpura, Thrombocytopenic, Idiopathic
  
• Rapid Infusion Of Immune Globulin Intravenous (IGIV) In Patients With ITP
  ClinicalTrials.gov Identifier: NCT00220727 - Completed
  Purpura, Thrombocytopenic
  
• Rituximab as Second Line Treatment for ITP
  ClinicalTrials.gov Identifier: NCT00344149 - Recruiting
  Idiopathic Thrombocytopenic Purpura
  
• Study of Doxil in the Treatment of Patients with Refractory Idiopathic Thrombocytopenic Purpura
  ClinicalTrials.gov Identifier: NCT00107913 - Recruiting
  Autoimmune Thrombocytopenic Purpura
  
• Efficacy and Safety of IVIG-L in ITP Patients
  ClinicalTrials.gov Identifier: NCT00151840 - Completed
  Purpura, Thrombocytopenic, Idiopathic
  
• Repeated Exposure to Eltrombopag in Adults With Idiopathic Thrombocytopenic Purpura (REPEAT)
  ClinicalTrials.gov Identifier: NCT00424177 - Active, not recruiting
  Chronic Idiopathic Thrombocytopenic Purpura
  
• IGIV Study for Chronic ITP Patients Ages 3-70
  ClinicalTrials.gov Identifier: NCT00511147 - Not yet recruiting
  Idiopathic Thrombocytopenic Purpura
  
• High Dose Dexamethasone Vs. Conventional Dose Prednisolone in Adult ITP
  ClinicalTrials.gov Identifier: NCT00451594 - Recruiting
  Idiopathic Thrombocytopenic Purpura
  
• Efficacy and Safety Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Adult Subjects with Chronic Idiopathic Thrombocytopenic Purpura
  ClinicalTrials.gov Identifier: NCT00162006 - Completed
  Idiopathic Thrombocytopenic Purpura
  
• Clinical Study to Evaluate the Efficacy and Safety of Octagam 10% in Idiopathic Thrombocytopenic Purpura in Adults
  ClinicalTrials.gov Identifier: NCT00426270 - Recruiting
  Idiopathic Thrombocytopenic Purpura
  
• Study of the Effectiveness of Rituximab in Adults With Chronic and Severe Immune Thrombocytopenic Purpura and Candidate for a Splenectomy
  ClinicalTrials.gov Identifier: NCT00225875 - Terminated
  Autoimmune Thrombocytopenic Purpura
  
• Pharmacokinetics and Pharmacodynamic Study of GMA161 in Patients With Idiopathic Thrombocytopenic Purpura
  ClinicalTrials.gov Identifier: NCT00244257 - Recruiting
  Idiopathic Thrombocytopenic Purpura
  
• A Study of MabThera (Rituximab) in Patients With Idiopathic Thrombocytopenic Purpura.
  ClinicalTrials.gov Identifier: NCT00475423 - Recruiting
  Idiopathic Thrombocytopenic Purpura
  
• Safety and Efficacy Study To Compare Uniplas With Cryosupernatant Plasma In Thrombotic Thrombocytopenic Purpura (TTP)
  ClinicalTrials.gov Identifier: NCT00411801 - Recruiting
  Thrombotic Thrombocytopenic Purpura (TTP)
  
• Transfusion Medicine/Hemostasis Clinical Research Network
  ClinicalTrials.gov Identifier: NCT00081718 - Recruiting
  Purpura, Thrombocytopenic; Blood Disease
  
• Rituximab and Prednisone as First-Line Therapy in Treating Patients With Immune Thrombocytopenic Purpura
  ClinicalTrials.gov Identifier: NCT00486421 - Recruiting
  Precancerous/Nonmalignant Condition
  
• ADAMTS13 in Thrombotic Thrombocytopenic Purpura
  ClinicalTrials.gov Identifier: NCT00426686 - Recruiting
  Thrombotic Thrombocytopenic Purpura
  
• A Study to Determine whether Therapy with Daclizumab Will Benefit Patients with Bone Marrow Failure
  ClinicalTrials.gov Identifier: NCT00001962 - Recruiting
  Aplastic Anemia; Pure Red Cell Aplasia; Thrombocytopenic Purpura
  
• Phase II Study of High-Dose Cyclophosphamide in Patients With Severe Autoimmune Hematologic Disease
  ClinicalTrials.gov Identifier: NCT00010387 - Active, not recruiting
  Anemia, Hemolytic, Autoimmune; Felty Syndrome; Purpura, Thrombocytopenic; Autoimmune Diseases
  
• Helicobacter Pylori Infection in Children With Chronic Idiopathic Thrombocytopenic Purpura
  ClinicalTrials.gov Identifier: NCT00467571 - Recruiting
  Chronic Idiopathic Thrombocytopenic Purpura; Helicobacter Pylori Infection
  
• Use of Rituximab Treatment in Addition to Standard Care for Newly Presenting Thrombotic Thrombocytopenic Purpura
  ClinicalTrials.gov Identifier: NCT00251277 - Recruiting
  Thrombotic Thombocytopenic Purpura; TTP; Hematology
  
• (Eltrombopag Extended Dosing Study)in Adults
  ClinicalTrials.gov Identifier: NCT00351468 - Recruiting
  Idiopathic Thrombocytopenic Purpura
  
• Rituximab in Patients With Relapsed or Refractory TTP-HUS
  ClinicalTrials.gov Identifier: NCT00531089 - Not yet recruiting
  Thrombotic Thrombocytopenic Purpura; Hemolytic Uremic Syndrome
  
• Drug Etiology of Aplastic Anemia and Related Dyscrasias
  ClinicalTrials.gov Identifier: NCT00005302 - Completed
  Blood Disease; Anemia, Aplastic; Agranulocytosis; Purpura, Thrombocytopenic
  
• Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases
  ClinicalTrials.gov Identifier: NCT00006055 - Active, not recruiting
  Purpura, Schoenlein-Henoch; Graft Versus Host Disease; Anemia, Hemolytic, Autoimmune; Rheumatoid Arthritis; Churg-Strauss Syndrome; ...
  
• Identifying Characteristics of Bone Marrow Failure Syndromes
  ClinicalTrials.gov Identifier: NCT00315419 - Recruiting
  Bone Marrow Failure Syndromes; Anemia, Aplastic; Myelodysplastic Syndromes; Hemoglobinuria, Paroxysmal; Red-Cell Aplasia, Pure; Purpura, Thrombocytopenic; Leukemia, Lymphocytic
  
• Efficacy of Steroid Versus Steroid Plus Cyclophosphamide for Severe Henoch-Schoenlein Purpura
  ClinicalTrials.gov Identifier: NCT00190229 - Active, not recruiting
  Henoch-Schoenlein Purpura
  
• HSP-Glomerulonephritis Trial: MP vs CyA
  ClinicalTrials.gov Identifier: NCT00425724 - Active, not recruiting
  Purpura, Schoenlein-Henoch
  
• MMF Versus Intravenous CTX Pulses in the Treatment of Adult Severe Henoch-Schonlein Purpura Nephritis
  ClinicalTrials.gov Identifier: NCT00301613 - Completed
  Henoch-Schoenlein Purpura; Nephritis
  
• A Phase III Randomized, Double-Blind, Controlled Study of the Use of Anti-HIV Immune Serum Globulin (HIVIG) for the Prevention of Maternal-Fetal HIV Transmission in Pregnant Women and Newborns Receiving Zidovudine (AZT)
  ClinicalTrials.gov Identifier: NCT00000751 - Active, not recruiting
  HIV Infections; Pregnancy
  
• Intravenous Pertussis Immune Globulin in Patients with Severe Childhood Pertussis Infection
  ClinicalTrials.gov Identifier: NCT00004422 - Active, not recruiting
  Pertussis; Whooping Cough
  
• Open Label, 48 Week Study of the Ability of Lopinavir/Ritonavir to Influence the Immune Response in Patients Who Are on an HIV Suppressive Regimen But Have Demonstrated a Blunted Immune Recovery.
  ClinicalTrials.gov Identifier: NCT00344487 - Recruiting
  HIV
  
• Influence of Persistent CMV-Infection on Immune Senescence
  ClinicalTrials.gov Identifier: NCT00461695 - Recruiting
  Immune Senescence
  
• Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00004744 - Active, not recruiting
  Multiple Sclerosis
  
• Safety and Immune Response to a Multi-Component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.
  ClinicalTrials.gov Identifier: NCT00423254 - Recruiting
  Advanced Cancer
  
• Safety and Efficacy of PRO 542 in the Treatment of HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00055185 - Active, not recruiting
  HIV Infections; Acquired Immune Deficiency Syndrome
  
• An Open Label, Sequential Cohort Dose Escalation Study to Evaluate the Safety and Efficacy of AMG 531 in Thrombocytopenic Subjects With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)
  ClinicalTrials.gov Identifier: NCT00548028 - Recruiting
  Myelodysplastic Syndrome (MDS); Thrombocytopenia
  
• Yoga, Immune Function, and Health
  ClinicalTrials.gov Identifier: NCT00371397 - Recruiting
  Immune Function
  
• Open Label Phase 3 Study of NABI-IGIV 10% [(HUMAN)] In Subjects With Primary Immune Deficiency Disorders (PIDD)
  ClinicalTrials.gov Identifier: NCT00538915 - Recruiting
  Primary Immune Deficiency Disorders; Antibody Deficiency Syndromes
  
• Booster Vaccination Study to Assess Immune Response & Safety of a Dose of GSK Biologicals’ Mencevax™ ACWY at 24-30 Mths Age & to Assess Immune Response & Safety of 1/5th of a Dose of Mencevax™ ACWY at 30-36 Mths Age in Subjects Primed in
  ClinicalTrials.gov Identifier: NCT00291343 - Active, not recruiting
  Diphtheria; Tetanus; Pertussis; Hepatitis B; Hib Diseases; Neisseria Meningitidis Serogroups A & C Diseases
  
• Ig NextGen 10% in Patients With Primary Immune Deficiency (PID)
  ClinicalTrials.gov Identifier: NCT00405184 - Recruiting
  Primary Immune Deficiency (PID)
  
• Influence of Corn Farming on the Immune System
  ClinicalTrials.gov Identifier: NCT00342121 - Active, not recruiting
  Cancer Risk
  
• Determination of the Optimal Prophylactic Platelet Dose Strategy to Prevent Bleeding in Thrombocytopenic Patients ( A TMH CTN Study)
  ClinicalTrials.gov Identifier: NCT00128713 - Recruiting
  Blood transfusion; Blood Platelets
  
• Safety and Immune Response of Different Pediatric Combination Vaccines.
  ClinicalTrials.gov Identifier: NCT00255047 - Active, not recruiting
  Diphtheria; Polio; Pertussis
  
• Pilot Study of Pyridostigmine Upon Immune Activation in HIV-1 Patients Who Have an Inadequate Immune Response
  ClinicalTrials.gov Identifier: NCT00518154 - Not yet recruiting
  HIV Infections
  
• Investigation of the Human Immune Response in Normal Subjects and Patients with Disorders of the Immune System and Cancer
  ClinicalTrials.gov Identifier: NCT00001582 - Recruiting
  Communicable Disease; Immunologic Deficiency Syndrome; Neoplasm
  
• MMF Monotherapy and Immune Regulation in Kidney Transplant Recipients: Part 1 Steroid Withdrawal
  ClinicalTrials.gov Identifier: NCT00214279 - Active, not recruiting
  Renal Transplantation
  
• Study to Assess the Immune Reactivity of the Liquid and Lyophilized Formulations of MEDI-493, Synagis
  ClinicalTrials.gov Identifier: NCT00233064 - Active, not recruiting
  Chronic Lung Disease
  
• A Study to Evaluate Immune Response and Safety of Two Doses of GSK Biologicals’ HRV Liquid Vaccine in Healthy Infants.
  ClinicalTrials.gov Identifier: NCT00432380 - Active, not recruiting
  Rotavirus Gastroenteritis
  
• Safety Study of Specific Tumor Target Drug Plus Immune System Therapy in Patients With Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00440973 - Active, not recruiting
  Carcinoma, Renal Cell
  
• Leukocyte Depletion of Autologous Whole Blood
  ClinicalTrials.gov Identifier: NCT00176124 - Active, not recruiting
  Transfusion Related Immune Reponse, Perioperative Infection Rate, Length of Hospital Stay in Hip Arthroplasty
  
• Analysis of the Immune Response to the Malaria Parasite in Mali, West Africa
  ClinicalTrials.gov Identifier: NCT00346346 - Active, not recruiting
  Malaria
  
• Characterisation of the Immune Responses of 2 Experimental Malaria Vaccines
  ClinicalTrials.gov Identifier: NCT00443131 - Active, not recruiting
  Plasmodium Falciparum Malaria
  
• Cell-Mediated Immune Responses to Influenza A/H5N1 Vaccine
  ClinicalTrials.gov Identifier: NCT00311727 - Active, not recruiting
  Influenza
  
• The Immune System and Psychiatric Disorders
  ClinicalTrials.gov Identifier: NCT00184418 - Active, not recruiting
  Stress; Depression; Mania; Personality Disorders; Schizophrenia
  
• Anorexia in Children With Burn Injury and the Reactions of the Immune and Endocrine Systems
  ClinicalTrials.gov Identifier: NCT00369876 - Active, not recruiting
  Burns; Anorexia
  
• Safety and Immune Response to a Prime-Boost Vaccination Schedule in HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00270465 - Active, not recruiting
  HIV
  
• Evaluation of the Safety and Effectiveness of a Probiotic Bacterium to Boost the Immune Response to Influenza Vaccines
  ClinicalTrials.gov Identifier: NCT00294788 - Active, not recruiting
  Influenza
  
• Demonstrate the Superiority of the Immune Response of Adjuvanted Influenza Vaccine Induced in an Adult Population
  ClinicalTrials.gov Identifier: NCT00377585 - Active, not recruiting
  Influenza
  
• Study Comparing the Immune Response and Safety of Fluarix and Fluzone Influenza Vaccines in Children
  ClinicalTrials.gov Identifier: NCT00383123 - Active, not recruiting
  Influenza
  
• Efficacy, Safety, Immunogenicity and Effect on Immune Response of Adalimumab Following Subcutaneous Administration in Patients With Active RA Treated Concomitantly With MTX.
  ClinicalTrials.gov Identifier: NCT00195702 - Active, not recruiting
  Rheumatoid Arthritis
  
• Study of the Safety and Immune Response of a Meningococcal Vaccine Administered to Healthy Infants
  ClinicalTrials.gov Identifier: NCT00262002 - Active, not recruiting
  Prevention of Meningococcal Disease
  
• Study of the Safety and Immune Response of a Meningococcal Vaccine Administered to Healthy Children
  ClinicalTrials.gov Identifier: NCT00262028 - Active, not recruiting
  Prevention of Meningococcal Disease
  
• The Effect of n-3 LCPUFA on Immune Function and Cardiovascular Risk Factors
  ClinicalTrials.gov Identifier: NCT00266292 - Active, not recruiting
  Cardiovascular Heart Disease; Metabolic Syndrome
  
• Immune Response Regulation in People Infected Concurrently With Malarial and Filarial Parasites
  ClinicalTrials.gov Identifier: NCT00341666 - Active, not recruiting
  Malaria; Filarial Infection
  
• The Immune Reactivity of Biofilms in Vaginal Mesh Erosion.
  ClinicalTrials.gov Identifier: NCT00564044 - Active, not recruiting
  Uterine Prolapse; Urinary Incontinence; Fecal Incontinence
  
• Vaccine Therapy Plus Immune Adjuvant in Treating Patients With Chronic Myeloid Leukemia, Acute Myeloid Leukemia, or Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00004918 - Active, not recruiting
  adult acute myeloid leukemia; atypical chronic myeloid leukemia; childhood acute myeloid leukemia and other myeloid malignancies; ...
  
• Study of the Safety and Immune Response of Two Serogroup B Meningococcal Vaccines Administered to Healthy Adolescents
  ClinicalTrials.gov Identifier: NCT00297817 - Active, not recruiting
  Prevention of Meningococcal Disease
  
• Changes in the Immune Response and Skin Reactivity of Grass Pollen Allergic Patients Treated With ALK Grass Tablets
  ClinicalTrials.gov Identifier: NCT00413556 - Active, not recruiting
  Allergy
  
• Study to Evaluate the Safety and Immune Response of Two-Doses of Candidate Influenza Vaccine GSK 1557484A in Adults
  ClinicalTrials.gov Identifier: NCT00510874 - Active, not recruiting
  Influenza
  
• Safety of and Immune Response to a Novel Human Papillomavirus Vaccine in HIV Infected Children
  ClinicalTrials.gov Identifier: NCT00339040 - Active, not recruiting
  HIV Infections; Sexually Transmitted Diseases
  
• Safety of and Immune Response to a Bird Flu Virus Vaccine (H9N2) in Healthy Adults (Study B)
  ClinicalTrials.gov Identifier: NCT00380237 - Active, not recruiting
  Influenza; Virus Diseases